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Hematopoietic Npc1 mutation 
shifts gut microbiota composition 
in Ldlr−/− mice on a high-fat,  
high-cholesterol diet
tom Houben  1, John penders  1*, Yvonne oligschlaeger1, inês A. Magro dos Reis1,  
Marc-Jan Bonder2, Debby p. Koonen3, Jingyuan fu2, Marten H. Hofker3 & Ronit Shiri-Sverdlov1*
While the link between diet-induced changes in gut microbiota and lipid metabolism in metabolic 
syndrome (MetS) has been established, the contribution of host genetics is rather unexplored. As 
several findings suggested a role for the lysosomal lipid transporter Niemann-Pick type C1 (NPC1) 
in macrophages during MetS, we here explored whether a hematopoietic Npc1 mutation, induced 
via bone marrow transplantation, influences gut microbiota composition in low-density lipoprotein 
receptor knockout (Ldlr−/−) mice fed a high-fat, high-cholesterol (HFC) diet for 12 weeks. Ldlr−/− mice 
fed a HFC diet mimic a human plasma lipoprotein profile and show features of MetS, providing a model 
to explore the role of host genetics on gut microbiota under MetS conditions. fecal samples were 
used to profile the microbial composition by 16 s ribosomal RNA gene sequencing. The hematopoietic 
Npc1 mutation shifted the gut microbiota composition and increased microbial richness and diversity. 
Variations in plasma lipid levels correlated with microbial diversity and richness as well as with several 
bacterial genera. This study suggests that host genetic influences on lipid metabolism affect the gut 
microbiome under MetS conditions. future research investigating the role of host genetics on gut 
microbiota might therefore lead to identification of diagnostic and therapeutic targets for MetS.
Metabolic syndrome (MetS) is a complex disorder that identifies centrally obese patients at increased risk for 
developing cardiovascular disease (CVD) and diabetes mellitus type 21,2. Due to the continuous increased preva-
lence of obesity, MetS is considered a global epidemic, putting an enormous pressure on health care services3. Next 
to insulin resistance and hypertension, another central abnormality observed within MetS are disturbances in 
lipid metabolism, resulting in dyslipidemia1,4. Dyslipidemia is characterized by increased plasma triglyceride-rich 
lipoproteins, decreased plasma high-density lipoprotein (HDL) and increased plasma low-density lipoprotein 
(LDL), leading to MetS-associated pathologies4.
Next to disturbances in plasma lipid levels, alterations in intracellular lipid metabolism have also been 
observed in MetS. While mutations in the gene encoding for the lysosomal membrane protein Niemann-Pick 
type C1 (NPC1) are well-known to induce a rare lysosomal storage disease, recent findings have also linked a 
dysfunctional NPC1 protein to the development of obesity and MetS5,6. Specifically, heterozygous Npc1 muta-
tion carriers showed a 4.8 higher risk for developing morbid adult obesity7. Moreover, identification of several 
Npc1 small nucleotide polymorphism (SNPs) via genome-wide association5 and confirmation studies8–10 have 
further highlighted the link between Npc1 variants (allele frequency ~38%) and obesity in the European popu-
lation. Mechanistically, a dysfunctional NPC1 protein leads to lysosomal lipid accumulation, thereby disturbing 
lipid metabolism11. Likewise, the phenomenon of lipid accumulation within the endo-lysosomal compartment 
of cells has also been observed in pathologies associated with MetS12. While lysosomal dysfunction in proxi-
mal tubular cells contributed to obesity-related kidney diseases13, lysosomal lipid storage within macrophages 
is a well-described mechanism disturbing general lipid metabolism and results in the induction of a chronic 
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low-grade inflammatory response in non-alcoholic steatohepatitis14,15 and atherosclerosis12,16–18. These findings 
imply a role for macrophage NPC1 in disturbing lipid homeostasis in MetS.
Relevantly, several studies have shown a link between the composition of the gut microbiota and lipid param-
eters such as LDL, triglyceride and HDL levels19–23. Moreover, modulating the gut microbiota by transferring 
the microbiota of lean donors has been shown to improve MetS in patients24, indicating the gut microbiota as 
a promising target to tackle metabolic disorders. However, the underlying mechanisms through which the gut 
microbiota modulates host’s metabolism remain largely elusive25. Gaining knowledge into the exact interactions 
between environment and host genetics on gut microbiota and associated pathophysiological processes is there-
fore essential to improve our diagnostic and therapeutic approaches to tackle metabolic pathologies.
The current study investigated whether a hematopoietic Npc1 mutation influences the gut microbiota in 
low-density lipoprotein receptor knockout (Ldlr−/−) mice fed a high-fat, high-cholesterol (HFC) diet for 12 
weeks. Ldlr−/− mice fed a HFC diet mimic a human plasma lipoprotein profile and show features of MetS26, pro-
viding a model to explore the role of host genetics on gut microbiota under MetS conditions. For this purpose, 
Ldlr−/− mice received bone marrow from Niemann-Pick type C1 mutant (Npc1mut) mice. This study suggests that 
host genetic influences related to lipid metabolism shift the gut microbiota composition and increases microbial 
richness and diversity under MetS conditions. Variations in plasma lipid levels correlated with microbial diversity 
and richness as well as with several bacterial genera. Future research investigating the role of host genetics on gut 
microbiota can therefore lead to identification of novel diagnostic and therapeutic targets for MetS.
Results
Hematopoietic Npc1 mutation disturbs intracellular and circulating lipid levels. To confirm 
successfulness of the bone marrow transplantation, intracellular and circulating lipid levels were measured in 
Npc1mut-tp Ldlr−/− mice. Subjecting Npc1mut-tp Ldlr−/− mice to a HFC diet for 12 weeks resulted in a strong increase 
in hepatic cholesterol levels, while a reduction was observed for hepatic triglyceride levels (Table 1). Moreover, due 
to the hematopoietic Npc1 mutation, hepatic lipids accumulated in the lysosomal fraction of hepatic macrophages 
(Fig. 1A,B and Supplementary Figs S1 and S2). Additionally, plasma cholesterol, triglyceride and free fatty acid levels 
decreased significantly, indicating a decrease of circulating lipids in Npc1mut-tp Ldlr−/− mice (Table 1). In line with 
these data, hepatic gene expression levels of ATP-binding cassette sub-family G member 1(Abcg1), Niemann-Pick 
type C2 (Npc2) and ATP-binding cassette transporter A1 (Abca1) increased in Npc1mut-tp Ldlr−/− mice. In spite of 
increased hepatic cholesterol levels (Table 1), these observations indicate increased hepatic cholesterol efflux signa-
ling, which is likely a compensation mechanism to overcome the accumulation of cholesterol in lysosomes. Overall, 
these data show that a hematopoietic Npc1 mutation induces lysosomal accumulation of lipids inside liver mac-
rophages and disturbs general lipid metabolism in Ldlr−/− mice on a HFC diet.
Microbial richness and diversity are increased and linked to lipid metabolism. To investigate the 
influence on microbial richness and diversity, α-diversity metrics were calculated. Both the observed microbial 
richness (observed number of OTUs) as well as the estimated richness as indicated by the Chao 1 index, was 
significantly higher in Ldlr−/− mice carrying the hematopoietic Npc1 mutation (Fig. 2A,B). Likewise, micro-
bial biodiversity, measured via the Shannon index (Fig. 2C) was significantly increased in Npc1mut-tp mice. To 
further define which variables are linked to microbial richness and diversity in this mouse model, Spearman 
correlation analysis was performed on all variables and the Chao 1 (richness) or Shannon (biodiversity) index. 
Plasma free fatty acids levels were negatively correlated with microbial richness (r = −0.47; p = 0.03) (Fig. 2D). 
Concomitantly, plasma total cholesterol levels showed the same inverse correlation with microbial richness 
(r = −0.41; p = 0.07) (Fig. 2E), though this correlation did not reach statistical significance. Furthermore, bio-
diversity correlated positively with hepatic gene expression levels of the intracellular cholesterol transporter 
Niemann-Pick type C2 (Npc2) (r = 0.47; p = 0.04) (Fig. 2F) and negatively with plasma total cholesterol levels 
(r = −0.56; p = 0.007) (Fig. 2G). Together, these data demonstrate that a hematopoietic Npc1 mutation in Ldlr−/− 
mice increases microbial richness and biodiversity, which is correlated to changes in lipid metabolism.
the microbial community structure is related to the hematopoietic Npc1 mutation but 
the latter is not linked to enterotypes. The dissimilarity in the microbial community composition 
(beta-diversity) of stool samples was assessed using the Bray-Curtis (BC) dissimilarities. Principal coordinate 
analysis (PCoA) based on Bray-Curtis dissimilarities showed that samples could be partly separated based upon 
Npc1wt-tp Ldlr−/− Npc1mut-tp Ldlr−/−
Liver total cholesterol (µg/mg dry weight) 47.03 ± 4.47 75.47 ± 2.51***
Liver total triglycerides (mg/mg protein) 0.51 ± 0.06 0.26 ± 0.04**
Plasma total cholesterol (mM) 38.53 ± 1.44 22.1 ± 1.09***
Plasma total triglycerides (mM) 3.82 ± 0.31 1.42 ± 0.15***
Plasma free fatty acids (mM) 1.33 ± 0.04 0.96 ± 0.05***
Abcg1 (Rel. Expr.) 1.00 ± 0.09 2.65 ± 0.13***
Npc2 (Rel. Expr.) 1.00 ± 0.1 3.06 ± 0.12***
Abca1 (Rel. Expr.) 1.00 ± 0.12 1.13 ± 0.06
Table 1. Intracellular and circulating lipid metabolism.
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the hematopoietic Npc1 mutation (Fig. 3A). Moreover, the within-group distance in microbial community struc-
ture (i.e. average Bray-Curtis dissimilarity between samples from the same treatment group) was significantly 
smaller than the between-group distance, indicating that the microbiota composition of animals within the same 
treatment group is more similar compared to animals from different treatment groups (Fig. 3B). Enterotype anal-
yses revealed two enterotypes driven by Allobaculum, Lactobacillus and S24-7 (Fig. 3C). However, the clustering 
was not associated with the bone marrow-specific Npc1 mutation.
To determine whether the hematopoietic Npc1 mutation or other variables had an additional effect on the gut 
microbiota community structure, we subsequently performed distance-based redundancy analysis (dbRDA); a 
constrained ordination technique. Constrained ordination techniques attempt to explain differences in micro-
bial composition between samples by differences in explanatory variables (e.g. hematopoietic Npc1 mutation). 
In db-RDA, the information from explanatory variables is combined with the eigenvalues obtained from the 
PCoA. Permutational multivariate analysis of variance (PERMANOVA) was used to determine significant dis-
similarity within bacterial communities and multiple explanatory variables. The hematopoietic Npc1 mutation 
(p = 0.034, explained variance = 18.9%) as well as hepatic gene expression levels of the cholesterol transporter 
Abcg1 (p = 0.041, explained variance = 20.8%) showed a relationship with the microbial community structure 
(Fig. 4A,B), whereas Abca1, Npc2, plasma total cholesterol, plasma total triglycerides, plasma free fatty acids, 
plasma cupper oxLDL, plasma EO6, cage number, liver total cholesterol and liver total triglycerides did not.
Hematopoietic Npc1 mutation shifts gut microbiota composition in Hfc-fed Ldlr−/− mice. 
Based on 16S rRNA gene sequencing, the dominant phyla/genera were selected for further analysis, lead-
ing to in depth analysis of 4 phyla and 44 genera (Fig. 5A,B). Firmicutes, Bacteroidetes and, to a lesser extent, 
Actinobacteria and Proteobacteria were the dominant observed phyla (Fig. 5A). The relative abundance of the 
bacterial phyla was not significantly different between Npc1wt- and Npc1mut-tp mice (Fig. 5A), however, within 
the Firmicutes phylum significant differences were observed in the relative abundance of several bacterial genera. 
Specifically, Staphylococcus spp. (p = 0.008; q = 0.34) and unclassified Mogibacteriaceae spp. (p = 0.008; q = 0.34) 
showed significantly higher levels in relative abundance in the Npc1mut-tp mice compared to Npc1wt-tp mice, 
whereas the abundance of Allobaculum spp. (p = 0.01, q = 0.34) was significantly lower (Fig. 5B–E). Relevantly, 
the unclassified Mogibacteriaceae spp. correlated with hepatic gene expression levels of Abcg1 (r = 0.57; p = 0.009) 
(Fig. 5F) and plasma total triglyceride levels (r = −0.41; p = 0.07), though the latter association was not 
Figure 1. Hepatic phenotype of HFC-fed Ldlr−/− mice carrying a hematopoietic Npc1 mutation. (A) 
Representative images of hepatic staining for hematoxylin and eosin (H&E), showing lysosomal lipid 
accumulation and granuloma formation in Npc1mut-transplanted Ldlr−/− mice. The left panel shows a normal 
view of the liver under high cholesterol conditions, with the green dots indicating lipid droplets. The right 
panel show clustering of foamy macrophages, referred to as granulomas (indicated by the asterisks). (B) 
Representative electron microscopy image of hepatic macrophages carrying a hematopoietic Npc1 mutation in 
HFC-fed Ldlr−/− mice, confirming the massive accumulation of lipids. The left panel shows a single Kupffer cell 
(K), surrounded by 2 hepatocytes (Hep.). The right panel shows the granuloma (surrounded by the dashed line), 
which is surrounded by Kupffer cells (K).
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statistically significant (Fig. 5G). Furthermore, the genus Allobaculum spp. showed a positive correlation with 
plasma free fatty acid levels (r = 0.52; p = 0.02) (Fig. 5H). Thus, a hematopoietic Npc1 mutation alters the compo-
sition of gut microbiota in HFC-fed Ldlr−/− mice, which are correlated with changes in lipid metabolism.
Discussion
Whereas increasing evidence has linked diet-induced changes in gut microbiota to perturbations in lipid metab-
olism in MetS, the contribution of host genetics to this relation is rather unexplored. This study suggests that host 
genetic influences on lipid metabolism such as a hematopoietic Npc1 mutation affect the gut microbiome under 
MetS conditions.
Though Npc1 was previously identified in a human GWAS for obesity5, our study is the first to imply its direct 
impact on the gut microbiome under MetS conditions. This observation suggests that host-derived genetic distur-
bances in lipid metabolism can impact the gut microbiome. Indeed, an increasing amount of reports have estab-
lished the capacity of the host’s genetic profile to shape the gut microbiome, thereby supporting our findings27,28. 
Also, the observation that a hematopoietic Npc1 mutation impacts the gut microbiota under MetS conditions 
confirms the previously established link between lipid metabolism and gut microbiota composition. However, 
in contrast to genetic manipulation of lipid metabolism, the link between lipid metabolism and gut microbiota 
has mainly been established based on studies wherein dietary components (i.e. high fat diet, prebiotics) altered 
lipid metabolism via influences on gut microbiota29,30. Therefore, in addition to gut microbiota-mediated influ-
ences of dietary compounds on lipid metabolism, our study implies that also host genetic factors that influence 
lipid metabolism can impact the gut microbiome. However, as we employed a HFC diet to both experimental 
conditions, the observed impact of the gut microbiota of the Npc1 mutation is likely also influenced by this diet. 
Indeed, previous reports have indicated that a high fat diet influences the composition of the gut microbiota31,32. 
Therefore, in spite of the observed changes in gut microbiota composition, to incontrovertibly demonstrate that 
Figure 2. Alpha diversity metrics in Ldlr−/− mice on HFC diet carrying a hematopoietic Npc1 mutation 
compared to wildtype. (A–C) The number of OTUs (A), Chao 1 index (B) and Shannon index (C) indicate 
increased diversity in Npc1mut-transplanted Ldlr−/− mice. (D–G) Spearman correlation between alpha diversity 
metrics and lipid parameters indicate a link between lipid metabolism and gut microbiota diversity. *Indicates 
p < 0.05. All errors are SEM.
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the hematopoietic Npc1 mutation influences gut microbiota composition, it is essential to investigate the gut 
microbiota of Npc1mut–tp Ldlr−/− mice receiving a normal chow diet.
Our results also shed new light on the association between overall health status and the gut bacterial richness 
and diversity. Here, under HFC conditions, induction of the pathological hematopoietic Npc1 mutation elevated 
bacterial richness and diversity. However, this is opposed to the concept that increased bacterial richness and 
diversity reflect ecosystem stability and resilience and is associated with overall health33–37. Yet, our apparent dis-
cordant finding on the association between disease and richness/diversity has also been observed by Kasai et al. 
who observed increased levels of bacterial diversity in obese compared to lean subjects38. Moreover, Vandeputte et 
al. associated stool consistency, potentially due to long colonic transit time39,40, with higher gut bacterial richness. 
Therefore, the increased bacterial richness and diversity observed in the pathological experimental group in the 
current study might have been influenced by stool consistency, hampering the view on bacterial richness and 
diversity as a marker for overall health status. Of note, while it is generally accepted that reduced plasma lipids 
are beneficial for health41, in the current model the reduced plasma lipids are a consequence of the accumulation 
of lipids inside macrophages (due to the Npc1 mutation). Therefore, the observed reduction in plasma lipids in 
our model is not considered beneficial for the health status, as these mice develop inflammation in the liver42 and 
arteries43.
Among the shifted gut bacteria after hematopoietic Npc1 mutation, we identified reduced relative abundances 
of the genus Allobaculum spp. Several studies have previously shown that Allobaculum spp. abundance is reduced 
in response to dietary fat intake44,45 and correlates with variations in plasma HDL concentrations46 and body 
weight47. In line, hepatic Abcg1 and Abca1 expression was increased in Npc1mut-tp mice, suggesting changes 
Figure 3. Principal Coordinate Analyses (PCoAs) based on Bray-Curtis distance and assortment of gut 
microbial communities into enterotypes for HFC-fed Ldlr−/− mice carrying a hematopoietic Npc1wt or Npc1mut 
mutation. (A) PCoA-plot based on unweighted UniFrac metrics for all samples showed that samples could 
be partly separated based upon the hematopoietic Npc1 mutation. (B) Bray-Curtis distances were calculated 
within Npc1wt-transplanted and Npc1mut-transplanted HFC-fed Ldlr−/− mice (average pairwise distance in 
microbiota composition between samples of the same experimental group) and between Npc1wt -transplanted 
and Npc1mut -transplanted HFC-fed Ldlr−/− mice (average pairwise distance between samples of different 
experimental groups), confirming the separation based on the hematopoietic Npc1 mutation. (C) Between-class 
analysis visualizing the two distinct enterotypes that could be identified based upon PAM clustering of Bray-
Curtis distances, with closed dots (Npc1mut) and squares (Npc1wt) representing individual mice and numbered 
white rectangles marking the center of each enterotype. Enterotypes were mainly driven by differential 
abundances in Allobaculum, Lactobacillus and S24-7, however the clustering was not associated with the bone 
marrow-specific Npc1 mutation. *Indicates p < 0.05.
6Scientific RepoRtS |         (2019) 9:14956  | https://doi.org/10.1038/s41598-019-51525-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
in lipid metabolism via lysosomal lipid-mediated activation of the transcription factor liver X receptor48,49. 
Therefore, our finding is consistent with the proposed view that Allobaculum spp. can be considered beneficial for 
the physiology of the host29. Next, in a prospective cross-sectional study, Staphylococcus spp. abundance was posi-
tively correlated with energy intake in obese children50. Here, we found an increased abundance of Staphylococcus 
spp. in HFC-fed Ldlr−/− mice carrying the hematopoietic Npc1 mutation. As such, Staphylococcus spp. might 
be involved in regulating the host’s lipid metabolism. Finally, increased relative abundances were observed of 
unclassified Mogibacteriaceae spp. in this study. Relevantly, a recent study by Harach et al. correlated levels of 
unclassified Mogibacteriaceae spp. with amyloid beta 42 levels in the brain of mice suffering from Alzheimer’s 
disease51. As multiple reports have previously linked a dysfunctional NPC1 protein to Alzheimer’s disease52–54, 
relative abundance changes in unclassified Mogibacteriaceae spp. might be directly related to mutations in Npc1 
and deserve further investigation. Of note, to ensure the causality between mutations in Npc1 and changes in gut 
microbiota composition, host responses should also be investigated in the future by means of fecal transplanta-
tion experiments. As such, the results in the current study do not provide information on causality, but are rather 
of associative nature.
Overall, this study suggests the impact of host genetic influences on lipid metabolism such as a hematopoietic 
Npc1 mutation on the gut microbiome in the context of MetS, confirming the link between lipid metabolism 
and gut microbiota. In addition, in contrast to previous studies, our findings suggest that increased microbial 
richness and diversity do not necessarily associate with improved health. Despite the significant associations 
between microbial richness and diversity and several lipid parameters, these Spearman correlations were rather 
Figure 4. Distance-based Redundancy Analysis (db-RDA) showing the relationship of the hematopoietic 
deficiency for Npc1 and Abcg1 to the microbial community structure. The plots represent a dbRDA ordination 
based upon the Bray-Curtis distance including (A) Npc1wt- and Npc1mut -transplanted Ldlr−/− mice with the 
hematopoietic Npc1 mutation as explanatory variable. This panel confirms the separation of the microbiota 
based on the hematopoietic Npc1 mutation. (B) Plasma cholesterol, plasma triglycerides, liver triglycerides, 
plasma free fatty acids, cage number, liver cholesterol, plasma EO6, plasma CuOxLDL and hepatic gene 
expression of Abcg1, Npc2, Npc1 and Abca1 as explanatory variables and samples colored to hepatic expression 
of Abcg1. Multivariate PERMANOVA analysis including all explanatory variables demonstrated that both Npc1 
and Abcg1 were significantly associated with the microbial community structure, while all other explanatory 
variables were not when mutually adjusting for each other. This plot further confirms that increased Npc1 
and Abcg1 expression levels are associated with similar changes in the microbial community structure. MDS1 
represents the unconstrained axis. CAP1 and CAP2 represent, respectively, the first and second constrained 
axes used in the CAP (canonical analysis of principal coordinates).
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low, potentially due to low sample size. As such, further research is necessary to confirm these associations. 
Finally, future research investigating the role of host genetics on gut microbiota is therefore warranted as it will 
increase our understanding of the function of the gut microbiome in human physiology and pathology.
Methods
experimental design. Niemann-Pick type C1nih mutant (Npc1mut) mice (a kind gift from Prof. Dr. 
Lieberman from University of Michigan Medical School) were backcrossed into a C57BL/6J background for 
more than 10 generations. Npc1mut and Ldlr−/− mice were housed under standard conditions and had access to 
food and water ad libitum. Experiments were performed according to Dutch regulations and approved by the 
Figure 5. Taxonomy at phylum and genus level for Npc1wt- and Npc1mut -transplanted HFC-fed Ldlr−/− 
mice. (A,B) Overview of the mean relative abundance at phylum level. (C) An overview of the mean relative 
abundance at genus level is given. Significant differences between the groups at genus level are presented in 
separate box-whiskers for Staphylococcus spp. (D), unclassified Mogibacteriaceae spp. (E) and Allobaculum 
spp. (F). (G–I) Spearman correlation between lipid parameters and relative abundances of unclassified 
Mogibacteriaceae spp. and Allobaculum spp. *Indicates p < 0.05 and ** p < 0.01.
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Committee for Animal Welfare of Maastricht University (approval number DEC 2011-133)42,43. Specifically, mice 
were housed in individually ventilated cages (IVC) in a conventional specified pathogenic free (SPF) facility 
where a 12 hr day/night cycle was handled using a dusk transition phase. Room temperature was kept constant 
at 21 °C. Corncob bedding material was used in the cages and animals were fed 10 mm food pellets that were 
irradiated with 25 kGray.
To generate myeloid Npc1mut deficient Ldlr−/− mice, a bone marrow transplantation was performed. 
Twenty-two week-old female Ldlr−/− mice received one week before and four weeks after irradiation antibiotic 
water containing 100 mg/l neomycin (Gibco, Breda, the Netherlands) and 6 * 104 U/l polymycin B Sulphate 
(Gibco, Breda, the Netherlands). One day before and on the day of the transplantation, Ldlr−/− mice were lethally 
irradiated with 6 Gray of γ-radiation in the morning, thus receiving 12 Gray in total. Lethally irradiated Ldlr−/− 
mice were then injected with 1 * 107 bone marrow cells donated from either Npc1mut mice or wildtype littermate 
controls (Npc1wt). In order to fully ensure bone marrow replacement, mice had a nine-week recovery period. After 
nine weeks of recovery, transplanted (-tp) mice received an HFC diet, containing 21% butter, 0.2% cholesterol, 
46% carbohydrates and 17% casein (diet 1635; Scientific Animal Food and Engineering, Villemoissonsur-Orge, 
France) for 12 weeks. We further highlight that the same mouse model as well as the described lipid measure-
ments were used in previously published manuscripts, where administration of dietary cholesterol was essential 
to induce lysosomal lipid-induced inflammation42,43,55. As we anticipated only subtle changes56 in the gut micro-
biome due to the Npc1 mutation being restricted to the hematopoietic line, we did not cohouse both genotypes. 
Though the influence of cage-effects cannot be completely excluded, the following measures were taken to mini-
mize the impact of housing conditions: the litters were separated per genotype after weaning, mice of similar age 
were used, the entire experiment was performed at once (so not over different time points), food and autoclaving 
parameters were standardized, only 1 person handled the mice throughout the entire experiment, mice were 
kept in cages in the same room, in the same rack and finally, mice of each genotype were put in four different 
cages. Finally, the between-genotype Bray-Curtis dissimilarity was significantly increased to the between-cage 
Bray-Curtis dissimilarity ((p = 0.03 compared to WT cages and p = 0.04 compared to Npc1mut cages), providing 
further evidence that the observed effects in the current study are at least partly due to the Npc1 mutation. Liver 
tissue was isolated and snap-frozen in liquid nitrogen and stored at −80 °C or fixed in 4% formaldehyde/PBS. The 
biochemical determination of plasma cholesterol and liver triglyceride levels, electron microscopy, RNA isolation, 
complementary DNA synthesis, quantitative polymerase chain reaction are described extensively42,43,57. Liver 
cholesterol levels were quantified as described previously58.
Sample collection and processing. Mice were housed in groups of 4 in separate cages, which were kept in 
the same room throughout the study. Fecal samples were snap-frozen with liquid nitrogen and stored at −80 °C. 
DNA isolation was done using the FavorPrep Stool DNA Isolation Mini Kit (FASTI 001-1) according to manu-
facturer’s protocol.
Sequencing. Amplicon libraries and sequencing was performed according to previously published proto-
cols19,59,60. Briefly, the hypervariable region V4 of the 16S rRNA gene was PCR amplified from each DNA sam-
ple using forward primer 515 F and reverse primer 806 R as described previously19. Illumina MiSeq paired end 
sequencing of equimorlarly pooled amplicons was subsequently used to determine the bacterial composition of 
fecal samples. Custom scripts were used to remove primer sequences, align paired end reads and quality-filter 
the sequencing reads. Details can be found in Fu et al.19 and Bonder et al.59. Sequencing data of all samples have 
been deposited in the European Bioinformatics Institute (EBI) database under primary accession code (ENA) 
PRJEB31646 and secondary accession code ERP114028.
Data analysis and statistics. Sequences were clustered into Operational Taxonomic Units (OTUs) using 
UCLUST (version 1.2.22q) at 97% similarity. For taxonomic assignments of OTUs, a TaxMan61 filtered and trun-
cated version of the full Greengenes reference database version 13.5 was used. OTUs that did not cluster against 
any of the sequences in the reference database were suppressed.
A total of 1,503,804 paired-end sequences, with a sequencing depth ranging from 15,637–117,585 reads/sam-
ple, were clustered in a total of 13,312 OTUs. To further reduce spurious OTUs and normalize for sequencing 
depth, data were rarefied to 10,000 reads/sample and OTUs containing less than 5 reads or occurring in only a 
single sample were discarded, resulting in a final number of 2.695 OTUs. Downstream analysis were conducted 
in QIIME version 1.962 and R version 3.1.3.
Microbial data-analyses and statistics. Taxonomic composition. Differences in the relative abun-
dance of bacterial phyla and genera between Npc1wt-tp and Npc1mut-tp Ldlr−/− mice were compared using the 
non-parametric t-test Metastats while controlling for multiple comparisons by means of the False Discovery Rate 
(q = 0.15; 750 permutations). Relations between bacterial phyla/genera and other continuous variables were ana-
lyzed via Spearman correlation using GraphPad Prism, version 6.0 for Windows. Though correlations between 
lipid parameters and gut microbiota abundances were calculated on pooled data to increase the power, it was 
verified whether both groups showed the same effect.
Microbial richness & diversity and microbial community structure. The following metrics of species richness 
and diversity within communities (alpha-diversity) were determined: observed OTUs (observed richness), 
Chao1 index (estimated richness), and Shannon diversity index. Alpha diversity metrics between the wild-type 
and mutant animals were compared by Mann Whitney tests using GraphPad Prism, version 6.0 for Windows. 
Beta-diversity, or diversity shared across samples was determined by the Bray-Curtis dissimilarity (BC) at 
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a rarefaction depth of 10,000 seq/sample (Supplementary Fig. S3). Clustering of samples was visualized using 
Principal Coordinate analysis (PCoA) followed by distance-based redundancy analysis (db-RDA), a constrained 
extension of PCoA. Db-RDA was performed in R63 package vegan using the capscale function. To determine to 
what extend the hematopoietic Npc1 mutation contributed in explaining the microbial community structure, 
we used variance partitioning with distance-based redundancy analysis (db-RDA) of Bray-Curtis distances. In a 
subsequent db-RDA, the following data were additionally included as explanatory variables to examine whether 
they had a significant impact on the microbial community structure: liver cholesterol, liver triglycerides, plasma 
cholesterol, plasma triglycerides, plasma free fatty acids, plasma cupper oxLDL, plasma EO6, cage number and 
hepatic gene expression of Abcg1, Npc2 and Abca1.
Enterotyping analyses. Enterotype analyses were performed as described previously by Armougham and col-
leagues64. Bray-Curtis (BC) distances were calculated for the genus-level relative abundance profiles. We used 
the R63 package “vegan: Community ecology”, version 2.2-1 by Oksanen et al. from 2011 for calculating the 
Bray-Curtis distances65.
To cluster the samples based on these distance metrics, we used the Partitioning Around Medoids (PAM) 
clustering algorithm in the R package “Cluster analysis basics and extensions”, version 2.0.1 ed. by Maechler et al. 
from 201266. The optimal number of clusters was chosen based on Calinski-Harabasz (CH) index and validated 
by the silhouette index67 using the R package ‘clusterSim’.
An optimal number of 2 clusters was identified based on the CH index, which was confirmed by the silhouette 
index although clustering was weak (SI 0.28).
Subsequent visualization and identification of relevant taxa was conducted for analyses based on BC distance. 
Between-class analysis (BCA) was performed to plot the samples using the R package “Analysis of Ecological 
Data: Exploratory and Euclidean Methods in Environmental Sciences” version 1.7.2. by Dray et al. from 2015. 
The similarity percentage analysis (SIMPER)68 was used to identify taxa contributing to similarity within- and 
dissimilarity between groups. Similar analyses have also been described previously60.
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